| Positive Rankings |
SSValue
The StockSelector Value for Abiomed is $280.85. The StockSelector Value assumes the market consistently prices a stock around a given PE ratio and, therefore, multiplies the average PE (using forward earnings estimates) over the past three years by future earnings estimates. Among companies with a StockSelector Value above the current stock price, Abiomed is ranked 90. |
90 Day Gain
Abiomed rank is 155 |
Up Ratings Revision
During the past month, the average analyst's rating or recommendation has increased. Among companies that have been upgraded within the past month, Abiomed is ranked 209. |
Debt-to-Equity
Abiomed rank is 225 |
Historic Revenue Growth
Abiomed rank is 362 |
Up EPS Surprise
Abiomed beat the consensus earnings estimate when it last reported quarterly earnings. |
Highest Net Margin
Abiomed rank is 1331 |
| Negative Rankings |
Negative Cash Growth
Abiomed rank is 121 |
High/Dropping MACD
The MACD remains positive, but is dropping... suggesting a possible near-term correction. Of companies with a positive, but declining MACD, Abiomed is ranked 338. |
Price-to-Book
Abiomed rank is 346 |
Negative ROA
Abiomed rank is 402 |
Negative ROE
Abiomed rank is 488 |
10 Day Loss
Abiomed rank is 1507 |
Price-to-Sales
Abiomed rank is 1586 |
